Beck Bode LLC’s Medtronic MDT Stock Holding History

Beck Bode LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-182	Closed	-$23K	–	205
2021 Q2	$23K	Buy	+182	New	+$22.9K	0.01%	186
2020 Q4	–	Sell	-182	Closed	-$19K	–	163
2020 Q3	$19K	Buy	+182	New	+$18.3K	0.01%	175

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's MDT Position: Q3 2021 in Review

Beck Bode LLC sold out of Medtronic (MDT) in Q3 2021, closing a stake of 182 shares — an estimated $23K sold.

Beck Bode LLC first reported a position in MDT in Q3 2020 and held it in 2 quarters. The position peaked at $23K in Q2 2021. 2,025 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Beck Bode LLC reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 182 Medtronic shares in Q3 2021, an estimated $23K.
Beck Bode LLC first reported a position in Medtronic in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's Medtronic position peaked at $23K in Q2 2021.
2,025 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.